Royal Liverpool pioneering treatment for rare liver cancer
RESEARCH: Researchers from the Royal Liverpool and Broadgreen University Hospitals Trust Royal have been pioneering an innovative new technique to treat patients with rare liver cancer hepatocellular carcinoma (HCC) that can extend their life expectancy and reduce side effects.
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- 10 expert briefings every fortnight (Premium only)
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)
Already a subscriber? Sign into your account here